Amrit Nagpal

Amrit Nagpal is a Managing Director at Redmile Group, a healthcare-focused investment firm based in San Francisco.13 He has held this position since January 2013.1 With over 20 years of experience in the financial sector, Nagpal has established himself as a prominent figure in healthcare investments.

Career History

• Managing Director at Redmile Group (January 2013 - Present)1
• Portfolio Manager/Partner at Weintraub Capital Management (September 2002 - December 2012)1
• Research Analyst at Robertson Stephens (September 1997 - May 2000)1

Education

• MBA in Finance from The Anderson School at UCLA (2000 - 2002)1
• Bachelor of Arts in Economics from Columbia University (1993 - 1997)1

Board Positions

Nagpal serves on several boards, including:

• Independent Director at Absci Corp. since October 20203
• Director at Covid Apollo Project LLC2
• Board Observer at ELECTRA Therapeutics4

Investment Expertise

At Redmile Group, Nagpal focuses on healthcare investments, leveraging his extensive experience in the field. Prior to joining Redmile, he spent a decade at Weintraub Capital Management LP, where he worked as both an analyst and portfolio manager.3

Nagpal's expertise in healthcare investments and his role at Redmile Group have positioned him as a key figure in the biotechnology and healthcare investment landscape.